4.6 Review

RNA Editors, Cofactors, and mRNA Targets: An Overview of the C-to-U RNA Editing Machinery and Its Implication in Human Disease

Journal

GENES
Volume 10, Issue 1, Pages -

Publisher

MDPI
DOI: 10.3390/genes10010013

Keywords

RNA editing; epitranscriptome; neurological disorders; AID/APOBEC

Funding

  1. ERC [649019]
  2. COST action [CA16120]
  3. European Research Council (ERC) [649019] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

One of the most prevalent epitranscriptomic modifications is RNA editing. In higher eukaryotes, RNA editing is catalyzed by one of two classes of deaminases: ADAR family enzymes that catalyze A-to-I (read as G) editing, and AID/APOBEC family enzymes that catalyze C-to-U. ADAR-catalyzed deamination has been studied extensively. Here we focus on AID/APOBEC-catalyzed editing, and review the emergent knowledge regarding C-to-U editing consequences in the context of human disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available